ABSI
Price
$2.97
Change
+$0.05 (+1.71%)
Updated
Dec 20, 04:59 PM (EDT)
88 days until earnings call
MDXG
Price
$9.11
Change
+$0.03 (+0.33%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
Ad is loading...

ABSI vs MDXG

Header iconABSI vs MDXG Comparison
Open Charts ABSI vs MDXGBanner chart's image
Absci
Price$2.97
Change+$0.05 (+1.71%)
Volume$25.81K
CapitalizationN/A
MiMedx Group
Price$9.11
Change+$0.03 (+0.33%)
Volume$5.5K
CapitalizationN/A
ABSI vs MDXG Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. MDXG commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and MDXG is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (ABSI: $2.97 vs. MDXG: $9.10)
Brand notoriety: ABSI and MDXG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 141% vs. MDXG: 183%
Market capitalization -- ABSI: $341.7M vs. MDXG: $1.34B
ABSI [@Biotechnology] is valued at $341.7M. MDXG’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileMDXG’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • MDXG’s FA Score: 1 green, 4 red.
According to our system of comparison, MDXG is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 3 TA indicator(s) are bullish while MDXG’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 3 bullish, 7 bearish.
  • MDXG’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MDXG is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -19.49% price change this week, while MDXG (@Biotechnology) price change was -0.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 19, 2025.

MDXG is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXG($1.34B) has a higher market cap than ABSI($342M). MDXG YTD gains are higher at: 3.763 vs. ABSI (-29.167). MDXG has higher annual earnings (EBITDA): 66.8M vs. ABSI (-83.27M). ABSI has more cash in the bank: 127M vs. MDXG (88.8M). ABSI has less debt than MDXG: ABSI (12M) vs MDXG (19M). MDXG has higher revenues than ABSI: MDXG (343M) vs ABSI (4.21M).
ABSIMDXGABSI / MDXG
Capitalization342M1.34B26%
EBITDA-83.27M66.8M-125%
Gain YTD-29.1673.763-775%
P/E RatioN/A15.93-
Revenue4.21M343M1%
Total Cash127M88.8M143%
Total Debt12M19M63%
FUNDAMENTALS RATINGS
MDXG: Fundamental Ratings
MDXG
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIMDXG
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DMCFX29.090.47
+1.64%
Invesco Discovery Mid Cap Growth R5
MYSPX63.000.68
+1.09%
NYLI S&P 500 Index Investor Class
MSOIX38.570.26
+0.68%
NYLI WMC Enduring Capital Class I
WAGSX12.250.07
+0.57%
Wasatch Global Select Investor
PSSRX24.120.03
+0.11%
PGIM Jennison Financial Services R

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+1.88%
BEAM - ABSI
48%
Loosely correlated
+8.16%
CRSP - ABSI
47%
Loosely correlated
+0.83%
PRME - ABSI
46%
Loosely correlated
+4.66%
RXRX - ABSI
45%
Loosely correlated
-0.90%
INZY - ABSI
45%
Loosely correlated
+6.41%
More

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
+0.22%
AXON - MDXG
47%
Loosely correlated
+2.59%
NTLA - MDXG
45%
Loosely correlated
+1.08%
EDIT - MDXG
42%
Loosely correlated
-2.24%
VCYT - MDXG
42%
Loosely correlated
+4.66%
AVXL - MDXG
41%
Loosely correlated
+1.89%
More